Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

Kirsten B. Bojesen, Bjørn H. Ebdrup, Kasper Jessen, Anne Sigvard, Karen Tangmose, Richard Anthony Edward Edden, Henrik B.W. Larsson, Egill Rostrup, Brian V. Broberg, Birte Y. Glenthøj

Research output: Contribution to journalArticle

Abstract

BackgroundPoor response to dopaminergic antipsychotics constitutes a major challenge in the treatment of psychotic disorders and markers for non-response during first-episode are warranted. Previous studies have found increased levels of glutamate and 3-aminobutyric acid (GABA) in non-responding first-episode patients compared to responders, but it is unknown if non-responders can be identified using reference levels from healthy controls (HCs).MethodsThirty-nine antipsychotic-naïve patients with first-episode psychosis and 36 matched HCs underwent repeated assessments with the Positive and Negative Syndrome Scale and 3T magnetic resonance spectroscopy. Glutamate scaled to total creatine (/Cr) was measured in the anterior cingulate cortex (ACC) and left thalamus, and levels of GABA/Cr were measured in ACC. After 6 weeks, we re-examined 32 patients on aripiprazole monotherapy and 35 HCs, and after 26 weeks we re-examined 30 patients on naturalistic antipsychotic treatment and 32 HCs. The Andreasen criteria defined non-response.ResultsBefore treatment, thalamic glutamate/Cr was higher in the whole group of patients but levels normalized after treatment. ACC levels of glutamate/Cr and GABA/Cr were lower at all assessments and unaffected by treatment. When compared with HCs, non-responders at week 6 (19 patients) and week 26 (16 patients) had higher baseline glutamate/Cr in the thalamus. Moreover, non-responders at 26 weeks had lower baseline GABA/Cr in ACC. Baseline levels in responders and HCs did not differ.ConclusionGlutamatergic and GABAergic abnormalities in antipsychotic-naïve patients appear driven by non-responders to antipsychotic treatment. If replicated, normative reference levels for glutamate and GABA may aid estimation of clinical prognosis in first-episode psychosis patients.

Original languageEnglish (US)
JournalPsychological medicine
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Psychotic Disorders
Antipsychotic Agents
Glutamic Acid
Gyrus Cinguli
Therapeutics
Thalamus
3-aminobutyric acid
Creatine
Magnetic Resonance Spectroscopy

Keywords

  • Anterior cingulate cortex
  • antipsychotic-naïve
  • first-episode psychosis
  • GABA
  • glutamate
  • magnetic resonance spectroscopy
  • thalamus
  • treatment outcome

ASJC Scopus subject areas

  • Applied Psychology
  • Psychiatry and Mental health

Cite this

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis. / Bojesen, Kirsten B.; Ebdrup, Bjørn H.; Jessen, Kasper; Sigvard, Anne; Tangmose, Karen; Edden, Richard Anthony Edward; Larsson, Henrik B.W.; Rostrup, Egill; Broberg, Brian V.; Glenthøj, Birte Y.

In: Psychological medicine, 01.01.2019.

Research output: Contribution to journalArticle

Bojesen, Kirsten B. ; Ebdrup, Bjørn H. ; Jessen, Kasper ; Sigvard, Anne ; Tangmose, Karen ; Edden, Richard Anthony Edward ; Larsson, Henrik B.W. ; Rostrup, Egill ; Broberg, Brian V. ; Glenthøj, Birte Y. / Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis. In: Psychological medicine. 2019.
@article{0cd9abc4ddd645029902570c3325b97b,
title = "Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-na{\"i}ve patients with psychosis",
abstract = "BackgroundPoor response to dopaminergic antipsychotics constitutes a major challenge in the treatment of psychotic disorders and markers for non-response during first-episode are warranted. Previous studies have found increased levels of glutamate and 3-aminobutyric acid (GABA) in non-responding first-episode patients compared to responders, but it is unknown if non-responders can be identified using reference levels from healthy controls (HCs).MethodsThirty-nine antipsychotic-na{\"i}ve patients with first-episode psychosis and 36 matched HCs underwent repeated assessments with the Positive and Negative Syndrome Scale and 3T magnetic resonance spectroscopy. Glutamate scaled to total creatine (/Cr) was measured in the anterior cingulate cortex (ACC) and left thalamus, and levels of GABA/Cr were measured in ACC. After 6 weeks, we re-examined 32 patients on aripiprazole monotherapy and 35 HCs, and after 26 weeks we re-examined 30 patients on naturalistic antipsychotic treatment and 32 HCs. The Andreasen criteria defined non-response.ResultsBefore treatment, thalamic glutamate/Cr was higher in the whole group of patients but levels normalized after treatment. ACC levels of glutamate/Cr and GABA/Cr were lower at all assessments and unaffected by treatment. When compared with HCs, non-responders at week 6 (19 patients) and week 26 (16 patients) had higher baseline glutamate/Cr in the thalamus. Moreover, non-responders at 26 weeks had lower baseline GABA/Cr in ACC. Baseline levels in responders and HCs did not differ.ConclusionGlutamatergic and GABAergic abnormalities in antipsychotic-na{\"i}ve patients appear driven by non-responders to antipsychotic treatment. If replicated, normative reference levels for glutamate and GABA may aid estimation of clinical prognosis in first-episode psychosis patients.",
keywords = "Anterior cingulate cortex, antipsychotic-na{\"i}ve, first-episode psychosis, GABA, glutamate, magnetic resonance spectroscopy, thalamus, treatment outcome",
author = "Bojesen, {Kirsten B.} and Ebdrup, {Bj{\o}rn H.} and Kasper Jessen and Anne Sigvard and Karen Tangmose and Edden, {Richard Anthony Edward} and Larsson, {Henrik B.W.} and Egill Rostrup and Broberg, {Brian V.} and Glenth{\o}j, {Birte Y.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1017/S0033291719002277",
language = "English (US)",
journal = "Psychological Medicine",
issn = "0033-2917",
publisher = "Cambridge University Press",

}

TY - JOUR

T1 - Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

AU - Bojesen, Kirsten B.

AU - Ebdrup, Bjørn H.

AU - Jessen, Kasper

AU - Sigvard, Anne

AU - Tangmose, Karen

AU - Edden, Richard Anthony Edward

AU - Larsson, Henrik B.W.

AU - Rostrup, Egill

AU - Broberg, Brian V.

AU - Glenthøj, Birte Y.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BackgroundPoor response to dopaminergic antipsychotics constitutes a major challenge in the treatment of psychotic disorders and markers for non-response during first-episode are warranted. Previous studies have found increased levels of glutamate and 3-aminobutyric acid (GABA) in non-responding first-episode patients compared to responders, but it is unknown if non-responders can be identified using reference levels from healthy controls (HCs).MethodsThirty-nine antipsychotic-naïve patients with first-episode psychosis and 36 matched HCs underwent repeated assessments with the Positive and Negative Syndrome Scale and 3T magnetic resonance spectroscopy. Glutamate scaled to total creatine (/Cr) was measured in the anterior cingulate cortex (ACC) and left thalamus, and levels of GABA/Cr were measured in ACC. After 6 weeks, we re-examined 32 patients on aripiprazole monotherapy and 35 HCs, and after 26 weeks we re-examined 30 patients on naturalistic antipsychotic treatment and 32 HCs. The Andreasen criteria defined non-response.ResultsBefore treatment, thalamic glutamate/Cr was higher in the whole group of patients but levels normalized after treatment. ACC levels of glutamate/Cr and GABA/Cr were lower at all assessments and unaffected by treatment. When compared with HCs, non-responders at week 6 (19 patients) and week 26 (16 patients) had higher baseline glutamate/Cr in the thalamus. Moreover, non-responders at 26 weeks had lower baseline GABA/Cr in ACC. Baseline levels in responders and HCs did not differ.ConclusionGlutamatergic and GABAergic abnormalities in antipsychotic-naïve patients appear driven by non-responders to antipsychotic treatment. If replicated, normative reference levels for glutamate and GABA may aid estimation of clinical prognosis in first-episode psychosis patients.

AB - BackgroundPoor response to dopaminergic antipsychotics constitutes a major challenge in the treatment of psychotic disorders and markers for non-response during first-episode are warranted. Previous studies have found increased levels of glutamate and 3-aminobutyric acid (GABA) in non-responding first-episode patients compared to responders, but it is unknown if non-responders can be identified using reference levels from healthy controls (HCs).MethodsThirty-nine antipsychotic-naïve patients with first-episode psychosis and 36 matched HCs underwent repeated assessments with the Positive and Negative Syndrome Scale and 3T magnetic resonance spectroscopy. Glutamate scaled to total creatine (/Cr) was measured in the anterior cingulate cortex (ACC) and left thalamus, and levels of GABA/Cr were measured in ACC. After 6 weeks, we re-examined 32 patients on aripiprazole monotherapy and 35 HCs, and after 26 weeks we re-examined 30 patients on naturalistic antipsychotic treatment and 32 HCs. The Andreasen criteria defined non-response.ResultsBefore treatment, thalamic glutamate/Cr was higher in the whole group of patients but levels normalized after treatment. ACC levels of glutamate/Cr and GABA/Cr were lower at all assessments and unaffected by treatment. When compared with HCs, non-responders at week 6 (19 patients) and week 26 (16 patients) had higher baseline glutamate/Cr in the thalamus. Moreover, non-responders at 26 weeks had lower baseline GABA/Cr in ACC. Baseline levels in responders and HCs did not differ.ConclusionGlutamatergic and GABAergic abnormalities in antipsychotic-naïve patients appear driven by non-responders to antipsychotic treatment. If replicated, normative reference levels for glutamate and GABA may aid estimation of clinical prognosis in first-episode psychosis patients.

KW - Anterior cingulate cortex

KW - antipsychotic-naïve

KW - first-episode psychosis

KW - GABA

KW - glutamate

KW - magnetic resonance spectroscopy

KW - thalamus

KW - treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=85072276740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072276740&partnerID=8YFLogxK

U2 - 10.1017/S0033291719002277

DO - 10.1017/S0033291719002277

M3 - Article

JO - Psychological Medicine

JF - Psychological Medicine

SN - 0033-2917

ER -